NewsBenzingaAdicet Bio To Report Clinical Data From Phase 1 Study Evaluating Prulacabtagene Leucel As Potential Treatment For Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis On September 28 Adicet Bio To Report Clinical Data From Phase 1 Study Evaluating Prulacabtagene Leucel As Potential Treatment For Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis On September 28 Benzinga 2026.09.25 20:01 (GMT+0) Open on Benzinga Other news CZ responds to deleting old crypto retweets: just testing an AI tool, no need to overinterpret Robotics Remains In Its ‘Lego Era,’ Says Former Nvidia Leader Turned VC as Physical AI Awaits Its ChatGPT Moment Cohen & Steers, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:CNS) 2026-10-17 UK Watchdog Proposes Strategic Market Tag for Microsoft, Puts Excel and Copilot AI Under Competition Scrutiny Here's What to Expect From Mid-America Apartment Communities' Next Earnings Report Parker Hannifin: Positive Business Outlook, But I Would Wait For A Pullback (NYSE:PH)
Robotics Remains In Its ‘Lego Era,’ Says Former Nvidia Leader Turned VC as Physical AI Awaits Its ChatGPT Moment
UK Watchdog Proposes Strategic Market Tag for Microsoft, Puts Excel and Copilot AI Under Competition Scrutiny
